rs2235000

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000051.4(ATM):​c.1541G>A​(p.Gly514Asp) variant causes a missense change. The variant allele was found at a frequency of 0.00324 in 1,614,114 control chromosomes in the GnomAD database, including 143 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G514C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.017 ( 68 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 75 hom. )

Consequence

ATM
NM_000051.4 missense

Scores

6
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:26O:1

Conservation

PhyloP100: 4.34

Publications

23 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030115843).
BP6
Variant 11-108251006-G-A is Benign according to our data. Variant chr11-108251006-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 133602.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0577 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.1541G>Ap.Gly514Asp
missense
Exon 10 of 63NP_000042.3
ATM
NM_001351834.2
c.1541G>Ap.Gly514Asp
missense
Exon 11 of 64NP_001338763.1Q13315

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.1541G>Ap.Gly514Asp
missense
Exon 10 of 63ENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.1541G>Ap.Gly514Asp
missense
Exon 11 of 64ENSP00000388058.2Q13315
ATM
ENST00000531525.3
TSL:1
c.1541G>Ap.Gly514Asp
missense
Exon 10 of 30ENSP00000434327.3H0YDU7

Frequencies

GnomAD3 genomes
AF:
0.0172
AC:
2616
AN:
152136
Hom.:
69
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0598
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00648
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00441
AC:
1108
AN:
251138
AF XY:
0.00296
show subpopulations
Gnomad AFR exome
AF:
0.0605
Gnomad AMR exome
AF:
0.00292
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.00164
GnomAD4 exome
AF:
0.00178
AC:
2605
AN:
1461860
Hom.:
75
Cov.:
35
AF XY:
0.00152
AC XY:
1103
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.0643
AC:
2154
AN:
33478
American (AMR)
AF:
0.00324
AC:
145
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000737
AC:
82
AN:
1111998
Other (OTH)
AF:
0.00333
AC:
201
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
150
300
451
601
751
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0172
AC:
2619
AN:
152254
Hom.:
68
Cov.:
32
AF XY:
0.0168
AC XY:
1252
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0597
AC:
2479
AN:
41522
American (AMR)
AF:
0.00647
AC:
99
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
68012
Other (OTH)
AF:
0.0114
AC:
24
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
131
263
394
526
657
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00542
Hom.:
91
Bravo
AF:
0.0197
ESP6500AA
AF:
0.0620
AC:
273
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00535
AC:
650
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
6
not specified (7)
-
-
5
Hereditary cancer-predisposing syndrome (5)
-
-
4
Ataxia-telangiectasia syndrome (4)
-
-
2
Familial cancer of breast (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.20
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.15
T
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.80
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-0.69
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
4.3
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.27
Sift
Benign
0.35
T
Sift4G
Benign
0.086
T
Polyphen
1.0
D
Vest4
0.74
MVP
0.92
MPC
0.36
ClinPred
0.041
T
GERP RS
6.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3
Varity_R
0.32
gMVP
0.40
Mutation Taster
=85/15
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2235000; hg19: chr11-108121733; COSMIC: COSV99069718; COSMIC: COSV99069718; API